Indegene shares may not see much upside, according to Nomura; here are the key risks

Nomura believes that Indegene has a scalable model, with domain expertise and a long-standing client relationships, positioning it well to capitalise on the digital adoption wave in the life sciences sector.

Leave a Reply

Your email address will not be published. Required fields are marked *